For grade 4 glioblastoma brain cancer, CCNB1 was indicated as a part of hub genes (with CDC6, KIF23, and KIF20A) and its expression correlated with prognosis, suggesting it as a potential biomarker for diagnosis and as a target for treatment [49]. The gene discussed is KIF23; the disease is glioblastoma.